These cancers are often difficult to diagnose early because of asymptomatic and heterogeneous appearance in early cancer stages [18], lower sensitivity of detection with ultrasound, lack of routine collection of cancer biomarkers (e.g., alpha‐fetoprotein) [19], and underutilization of surveillance in the US when compared to countries with higher rates of liver cancer [20]. This evidence concerns the gene AFP and cancer.